Promotions and hires for September 26, 2008:
Merck named Barry J. Goldstein, M.D., vice president of clinical development for diabetes and obesity
Sanofi-Aventis announced that Chris Viehbacher will succeed current CEO Gerard Le Fur in December
GlaxoSmithKline named Ellen Strahlman chief medical officer
Questcor Pharmaceuticals appointed Gary Sawka CFO
Encorium appointed David Ginsberg president and CEO
Wyeth named Daniel J. [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Moving On + Up